Healthcare Distribution Alliance – Patients Move Us.
Share Print
News

News

HDA Statement on U.S. District Court Ruling in Huntington and Cabell County, West Virginia

July 7, 2022

ARLINGTON, Va. — The Healthcare Distribution Alliance released the following statement on the ruling by the U.S. District Court for the Southern District of West Virginia regarding the litigation in Huntington and Cabell County.

“We are pleased with the ruling by U.S. District Judge David A. Faber, which affirmed that pharmaceutical distributors do not bear responsibility for the opioid crisis in Cabell County and the City of Huntington. Our industry works each day in tandem with supply chain partners as well as federal and state authorities to ensure a safe and secure distribution channel for all prescription medicines across the United States — and we remain committed to advancing meaningful educational initiatives to address the misuse and abuse of prescription opioids.”

ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE

The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.

CONTACT

© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365